In order to investigate whether UBA1 can predict treatment response to cancer, data was obtained from ROCplotter to demonstrate the association between treatment outcomes and UBA1 expression for four types of cancer (BRCA, OV, GBM, and CRC). This evidence concerns the gene UBA1 and colorectal carcinoma.